A cura di Simona Lucchesi. UOSD Farmacologia Clinica. AOU “G. Martino” Messina
|
Principio attivo |
Effetto |
|
Esomeprazolo (1-2) |
Aumento della biodisponibilità dell’acido risedronico |
Bibliografia
- Product Information: Atelvia(R) oral delayed release tablets, risedronate sodium oral delayed release tablets. Warner Chilcott (US), LLC (per FDA), Rockaway, NJ, Jul, 2012.
- Product Information: Nexium(R) I.V. intravenous injection, esomeprazole sodium intravenous injection. AstraZeneca LP (per FDA), Wilmington, DE, Jan, 2012.